Kirkland & Ellis Hired for Big Pharma Antitrust Suit

A 2020 verdict allowed Teva and other companies to produce generic versions of Vascepa. But Teva allegedly had to scale back its launch because of an inability to obtain the key ingredient, the suit said.


Related Articles


Your email address will not be published. Required fields are marked *